Hexagon Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Hexagon Capital Partners's LLY Position: Q3 2026 in Review
Hexagon Capital Partners increased its Eli Lilly (LLY) stake by 7.1% in Q3 2026, buying an estimated $99.1K and bringing the position to 1,268 shares worth $1.47M. The position accounts for 0.21% of the portfolio, ranked #51.
Hexagon Capital Partners first reported a position in LLY in Q3 2020 and has held it in 22 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Hexagon Capital Partners held 1,268 shares of Eli Lilly worth $1.47M as of Q3 2026.
- Hexagon Capital Partners bought 84 Eli Lilly shares in Q3 2026, an estimated $99.1K.
- Eli Lilly made up 0.21% of Hexagon Capital Partners's portfolio in Q3 2026, its #51 holding.
- Hexagon Capital Partners first reported a position in Eli Lilly in Q3 2020 and has held it in 22 quarters since.
- 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Hexagon Capital Partners's 13F filing for Q3 2026, filed 12 Nov 2026.